tiprankstipranks
Advertisement
Advertisement

AU:SNT Stock Latest News

Syntara Issues Over 1.15 Million Unquoted Performance Rights Under Incentive Plan
Company AnnouncementsSyntara Issues Over 1.15 Million Unquoted Performance Rights Under Incentive Plan
5d ago
Syntara Flags Risks and Uncertainty Around Future Plans
PremiumCompany Announcements
Syntara Flags Risks and Uncertainty Around Future Plans
18d ago
Syntara to Spotlight Expanding Drug Pipeline at NWR Virtual Healthcare Conference
PremiumCompany Announcements
Syntara to Spotlight Expanding Drug Pipeline at NWR Virtual Healthcare Conference
19d ago
Syntara secures Parkinson’s UK milestone as Phase 2 iRBD trial fully dosed
PremiumCompany Announcements
Syntara secures Parkinson’s UK milestone as Phase 2 iRBD trial fully dosed
24d ago
Syntara Clears 614,369 Lapsed Performance Rights From Capital Structure
PremiumCompany Announcements
Syntara Clears 614,369 Lapsed Performance Rights From Capital Structure
1M ago
Syntara Seeks ASX Quotation for 609,670 Newly Issued Shares
PremiumCompany AnnouncementsSyntara Seeks ASX Quotation for 609,670 Newly Issued Shares
1M ago
Syntara Posts Deeper Half-Year Loss as Revenue Slides and Asset Backing Thins
Premium
Company Announcements
Syntara Posts Deeper Half-Year Loss as Revenue Slides and Asset Backing Thins
1M ago
Syntara Seeks ASX Quotation for 445,750 New Ordinary Shares
Premium
Company Announcements
Syntara Seeks ASX Quotation for 445,750 New Ordinary Shares
2M ago
Syntara Highlights Risks and Uncertainty Around Forward-Looking Statements
PremiumCompany Announcements
Syntara Highlights Risks and Uncertainty Around Forward-Looking Statements
2M ago
Syntara Cautions Investors on Risks in Forward-Looking Statements
PremiumCompany Announcements
Syntara Cautions Investors on Risks in Forward-Looking Statements
2M ago
Syntara Seeks ASX Quotation for 634,110 Additional Shares
PremiumCompany Announcements
Syntara Seeks ASX Quotation for 634,110 Additional Shares
2M ago
Syntara Sets Investor Webinar Ahead of Pivotal 2026 Clinical Readouts
PremiumCompany Announcements
Syntara Sets Investor Webinar Ahead of Pivotal 2026 Clinical Readouts
2M ago
Syntara Targets Pivotal 2026 as Lead Cancer Drug and Pipeline Advance
PremiumCompany AnnouncementsSyntara Targets Pivotal 2026 as Lead Cancer Drug and Pipeline Advance
2M ago
Syntara’s Amsulostat to Join MRFF-Funded Pancreatic Cancer Trials as Non-Dilutive Backing Tops A$10m
Premium
Company Announcements
Syntara’s Amsulostat to Join MRFF-Funded Pancreatic Cancer Trials as Non-Dilutive Backing Tops A$10m
3M ago
Syntara Names CFO Tim Luscombe as New Company Secretary
Premium
Company Announcements
Syntara Names CFO Tim Luscombe as New Company Secretary
3M ago
Syntara Completes Phase 2 Recruitment for Neuroinflammation Drug in High-Risk Sleep Disorder
PremiumCompany Announcements
Syntara Completes Phase 2 Recruitment for Neuroinflammation Drug in High-Risk Sleep Disorder
3M ago
Syntara Positions for Transformational 2026 as Multiple Clinical Programs Near Key Readouts
PremiumCompany Announcements
Syntara Positions for Transformational 2026 as Multiple Clinical Programs Near Key Readouts
4M ago
Syntara Limited Showcases Promising Amsulostat Data at ASH Meeting
PremiumCompany Announcements
Syntara Limited Showcases Promising Amsulostat Data at ASH Meeting
4M ago
Syntara Limited Highlights Uncertainty in Future Projections
PremiumCompany Announcements
Syntara Limited Highlights Uncertainty in Future Projections
5M ago
Syntara Limited Announces Director’s Interest Change
PremiumCompany AnnouncementsSyntara Limited Announces Director’s Interest Change
5M ago
Syntara Limited Announces Director’s Increased Share Options
Premium
Company Announcements
Syntara Limited Announces Director’s Increased Share Options
5M ago
Syntara Limited Issues New Performance Rights
Premium
Company Announcements
Syntara Limited Issues New Performance Rights
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >